Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation

NCT05995899 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

IBS
IBS - Irritable Bowel Syndrome

Interventions

DRUG: Tenapanor

Sponsor

Kyle Staller, MD, MPH

Collaborators

[object Object]